Integrated Diagnostics Holdings PLC Holding(s) in Company (1881Z)
11 March 2017 - 1:55AM
UK Regulatory
TIDMIDHC
RNS Number : 1881Z
Integrated Diagnostics Holdings PLC
10 March 2017
For filings with the FCA
include the annex
For filings with issuer exclude
the annex
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES(i)
---------------------------------------------------------------------------------------------
1. Identity of the issuer or INTEGRATED DIAGNOSTICS
the underlying issuer HOLDINGS PLC
of existing shares to which
voting rights are
attached: (ii)
----------------------------------------------------------- --------------------------------
2 Reason for the notification (please tick the appropriate
box or boxes):
---------------------------------------------------------------------------------------------
An acquisition or disposal of voting rights X
------------------------------------------------------------ -------------------------------
An acquisition or disposal of qualifying financial
instruments which may result in the acquisition
of shares already issued to which voting rights
are attached
------------------------------------------------------------ -------------------------------
An acquisition or disposal of instruments with
similar economic effect to qualifying financial
instruments
------------------------------------------------------------ -------------------------------
An event changing the breakdown of voting rights
------------------------------------------------------------ -------------------------------
Other (please
specify):
---------------------------------------------------------- -------------------------------
3. Full name of person(s) T. Rowe Price Associates,
subject to the Inc.
notification obligation:
(iii)
----------------------------------------------------------- --------------------------------
4. Full name of shareholder(s) JP Morgan Chase
(if different from 3.):(iv) Bank of New York Mellon Bank,
N.A.
Northern Trust Co.
----------------------------------------------------------- --------------------------------
5. Date of the transaction 08 March 2017
and date on
which the threshold is
crossed or
reached: (v)
----------------------------------------------------------- --------------------------------
6. Date on which issuer 10 March 2017
notified:
----------------------------------------------------------- --------------------------------
7. Threshold(s) that is/are
crossed or
reached: (vi, vii) 5%
----------------------------------------------------------- --------------------------------
8. Notified details:
----------------------------------------------------------------------------------------------------------------------
A: Voting rights attached to shares (viii, ix)
----------------------------------------------------------------------------------------------------------------------
Class/type Situation previous Resulting situation after the
of to the triggering triggering transaction
shares transaction
if possible
using
the ISIN
CODE
------------- ---------------------------------- -------------------------------------------------------------------
Number Number Number Number of % of voting
of of of shares voting rights (x)
Shares Voting rights
Rights
------------- ---------------- ---------------- -------------- ------------------------ -------------------------
Direct Direct Indirect Direct Indirect
(xi) (xii)
------------- ------------ ------------ -------------- --------- ------------- ------------ -----------
JE00BV9H9G76 7,474,850 7,474,850 7,570,134 7,570,134 5.04%
---------------- ---------------- -------------- --------- ------------- ------------ -----------
B: Qualifying Financial Instruments
----------------------------------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
----------------------------------------------------------------------------------------------------------------------
Type of Expiration Exercise/ Number of voting % of voting
financial date Conversion rights that rights
instrument (xiii) Period (xiv) may be
acquired if
the
instrument
is
exercised/
converted.
----------------- -------------- -------------------------------- -------------------------- ---------------------
C: Financial Instruments with similar economic effect
to Qualifying Financial Instruments (xv, xvi)
----------------------------------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
----------------------------------------------------------------------------------------------------------------------
Type of Exercise Expiration Exercise/ Number of voting % of voting
financial price date Conversion rights instrument rights (xix,
instrument (xvii) period refers to xx)
(xviii)
--------------- -------------- -------------- ---------------- -------------------------- -----------------------
Nominal Delta
--------------- -------------- -------------- ---------------- -------------------------- ------------ ---------
Total (A+B+C)
----------------------------------------------------------------------------------------------------------------------
Number of voting rights Percentage of voting rights
--------------------------------------------------- -----------------------------------------------------------------
7,570,134 5.04%
--------------------------------------------------- -----------------------------------------------------------------
9. Chain of controlled undertakings through which the
voting rights and/or the
financial instruments are effectively held, if applicable:
(xxi)
------------------------------------------------------------------------------------------
T. Rowe Price Associates, Inc. (TRPA) serves as investment
adviser, with dispositive and voting authority, to various
institutional clients that own shares of Integrated
Diagnostics Holding Plc., including the T. Rowe Price
International Discovery Fund, which owns 5,391,836 shares.
Such shares are registered in the following name(s):
Bank of New York Mellon Bank, N.A. - 337,429
JP Morgan Chase - 7,172,393
Northern Trust Co. - 60,312
Proxy Voting:
------------------------------------------------------------------------------------------
10. Name of the proxy holder:
------------------------------------------------------------- ---------------------------
11. Number of voting rights proxy
holder will cease to hold:
------------------------------------------------------------- ---------------------------
12. Date on which proxy holder will
cease to hold voting rights:
------------------------------------------------------------- ---------------------------
13. Additional information:
------------------------------------------------------------- ---------------------------
14. Contact name: Gary Greb, Vice President
T. Rowe Price Associates,
Inc.
------------------------------------------------------------- ---------------------------
15. Contact telephone number: 001 410 345 2527
------------------------------------------------------------- ---------------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLURVSRBSAOAAR
(END) Dow Jones Newswires
March 10, 2017 09:55 ET (14:55 GMT)
Integrated Diagnostics (LSE:IDHC)
Historical Stock Chart
From Apr 2024 to May 2024
Integrated Diagnostics (LSE:IDHC)
Historical Stock Chart
From May 2023 to May 2024